As of 10:04am ET
| +0.18 / +2.60%|
The 8 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 13.62, with a high estimate of 22.40 and a low estimate of 5.01. The median estimate represents a +92.17% increase from the last price of 7.09.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.